(SAN ANTONIO, TX – June 6, 2017)— Our CHRISTUS Santa Rosa Hospitals have received the American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Silver Plus Quality Achievement Award with Target: StrokeSM Honor Roll. The award recognizes the hospitals’ commitment and success ensuring that stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.
“A stroke patient loses 1.9 million neurons each minute stroke treatment is delayed. This recognition further demonstrates our commitment to delivering advanced stroke treatments to patients quickly and safely,” said Cori Nash, BSN, RN, CVRN-BC, regional stroke program coordinator, CHRISTUS Santa Rosa Health System. “CHRISTUS Santa Rosa continues to strive for excellence in the acute treatment of stroke patients. The recognition from the American Heart Association/American Stroke Association reinforces our
team’s hard work.”
According to research, stroke is the No. 5 cause of death and a leading cause of adult disability in the United States. On average, someone in the U.S. suffers a stroke every 40 seconds, someone dies of a stroke every four minutes, and nearly 800,000 people suffer a new or recurrent stroke each year. CHRISTUS Santa Rosa’s stroke recognition extends to its Hospitals at Westover Hills, Medical Center, New Braunfels, CHRISTUS Santa Rosa Emergency Center – Alon, and CHRISTUS Santa Rosa Emergency Center – Creekside.
To receive the Silver Plus Quality Achievement Award, hospitals must achieve 85 percent or higher adherence to all Get With The Guidelines-Stroke achievement indicators for at least 12 consecutive months and during the same period achieve 75 percent or higher compliance with five of eight Get With The Guidelines-Stroke Quality measures.
To qualify for the Target: Stroke Honor Roll, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. If given intravenously in the first three hours after the start of stroke symptoms, tPA has been shown to significantly reduce the effects of stroke and lessen the chance of permanent disability. Our facilities earned the award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period.
These quality measures are designed to help hospital teams follow the most up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients.
“The American Heart Association and American Stroke Association recognize CHRISTUS Santa Rosa for its commitment to stroke care,” said Paul Heidenreich, M.D., M.S., national chairman of the Get With The Guidelines Steering Committee and Professor of Medicine at Stanford University. “Research has shown there are benefits to patients who are treated at hospitals that have adopted the Get With The Guidelines program.”